Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 5.20% is 106% above its 5-year average of 2.52%, near the high end of its 5-year range (-6.98%–5.78%).
2.26% above its 12-month average of 5.08%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-06-30): 0.70%.
RETURN ON ASSETS (ROA)
5.20%
RETURN ON ASSETS (ROA) AVG TTM
5.08%
RETURN ON ASSETS (ROA) AVG 3Y
5.08%
RETURN ON ASSETS (ROA) AVG 5Y
2.52%
RETURN ON ASSETS (ROA) AVG 10Y
2.66%
RETURN ON ASSETS (ROA) AVG 15Y
3.19%
RETURN ON ASSETS (ROA) AVG 20Y
3.37%
CURRENT VS TTM AVG
+2.26%
CURRENT VS 3Y AVG
+2.31%
CURRENT VS 5Y AVG
+106.49%
CURRENT VS 10Y AVG
+95.62%
CURRENT VS 15Y AVG
+63.05%
CURRENT VS 20Y AVG
+54.50%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+1.17%
vs the sector median at left
McKesson Corporation
Market Cap
$102.98B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$107.39B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$92.89B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$115.18B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$89.84B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$118.75B
Return on Assets (ROA)
5.61%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$81.33B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $102.98B | 5.20% | 5.08% | 5.08% | 2.52% |
| Sanofi (SNY)vs › | $103.59B | 3.12% | 5.18% | 5.31% | 6.19% |
| GSK plc (GSK)vs › | $102.30B | 7.91% | 6.85% | 11.28% | 9.07% |
| Stryker Corporation (SYK)vs › | $107.39B | 7.78% | 6.88% | 7.02% | 6.41% |
| HCA Healthcare, Inc. (HCA)vs › | $92.89B | 11.30% | 10.43% | 10.23% | 10.42% |
| CVS Health Corp. (CVS)vs › | $115.18B | 1.93% | 1.25% | 1.93% | 2.38% |
| Elevance Health Inc. (ELV)vs › | $89.84B | 3.93% | 4.89% | 5.25% | 5.41% |
| Medtronic plc (MDT)vs › | $118.75B | 5.61% | 5.13% | 4.62% | 4.65% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.33B | 10.37% | 11.40% | 12.40% | 16.97% |
| Bristol-Myers Squibb Company (BMY)vs › | $128.36B | 10.59% | -0.92% | 3.28% | 1.99% |
ROA
5.2%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | 5.78% |
| 2025-03-31 | 4.39% |
| 2024-03-31 | 4.45% |
| 2023-03-31 | 5.71% |
| 2022-03-31 | 1.76% |
| 2021-03-31 | -6.98% |
| 2020-03-31 | 1.47% |
| 2019-03-31 | 0.06% |
| 2018-03-31 | 0.11% |
| 2017-03-31 | 8.50% |
| 2016-03-31 | 3.99% |
| 2015-03-31 | 2.74% |
| 2014-03-31 | 2.44% |
| 2013-03-31 | 3.85% |
| 2012-03-31 | 4.24% |
| 2011-03-31 | 3.66% |
| 2010-03-31 | 4.48% |
| 2009-03-31 | 3.26% |
| 2008-03-31 | 4.02% |
| 2007-03-31 | 4.02% |
| 2006-03-31 | 3.52% |
| 2005-03-31 | -0.84% |
| 2004-03-31 | 3.98% |
| 2003-03-31 | 3.87% |
| 2002-03-31 | 3.14% |
| 2001-03-31 | -0.42% |
| 2000-03-31 | 6.98% |
| 1999-03-31 | 0.93% |
| 1998-03-31 | 2.76% |
| 1997-03-31 | 2.59% |
